Search Results

There are 16644 results for: content related to: Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease

  1. Gender and BCR-ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia

    European Journal of Haematology

    Volume 96, Issue 4, April 2016, Pages: 360–366, Han-Xin Lin, Jenny Sjaarda, Jocob Dyck, Randa Stringer, Chris Hillis, Maria Harvey, Ronald Carter, Peter Ainsworth, Brian Leber, Guillaume Pare and Bekim Sadikovic

    Version of Record online : 3 JUL 2015, DOI: 10.1111/ejh.12597

  2. You have free access to this content
    The early molecular response to imatinib predicts cytogenetic and clinical outcome in chronic myeloid leukaemia

    British Journal of Haematology

    Volume 120, Issue 6, March 2003, Pages: 990–999, Lihui Wang, Kevin Pearson, Julia E. Ferguson and Richard E. Clark

    Version of Record online : 18 MAR 2003, DOI: 10.1046/j.1365-2141.2003.04200.x

  3. Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

    American Journal of Hematology

    Volume 90, Issue 11, November 2015, Pages: 1013–1020, Sung-Nam Lim, Young-Don Joo, Kyoo-Hyung Lee, Dae-Young Kim, Je-Hwan Lee, Jung-Hee Lee, Hyun-Sook Chi, Sung-Cheol Yun, Won Sik Lee, Sang Min Lee, Seonyang Park, Inho Kim, Sang Kyun Sohn, Joon Ho Moon, Hun-Mo Ryoo, Sung Hwa Bae, Myung Soo Hyun, Min Kyoung Kim, Hyeoung Joon Kim, Deok-Hwan Yang, Hyeon-Seok Eom1, Gyeong-Won Lee, Chul Won Jung, Jong-Ho Won, Hawk Kim, Jae-Hoon Lee, Ho-Jin Shin and Dae-Young Jang

    Version of Record online : 12 OCT 2015, DOI: 10.1002/ajh.24137

  4. You have free access to this content
    Recent developments in drug resistance mechanism in chronic myeloid leukemia: a review

    European Journal of Haematology

    Volume 87, Issue 5, November 2011, Pages: 381–393, Shantashri Vaidya, Kanjaksha Ghosh and Babu Rao Vundinti

    Version of Record online : 2 OCT 2011, DOI: 10.1111/j.1600-0609.2011.01689.x

  5. Quantitative real-time reverse-transcription polymerase chain reaction for diagnosis of BCR-ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation

    European Journal of Haematology

    Volume 70, Issue 1, January 2003, Pages: 1–10, Frank Neumann, Caroline Herold, Barbara Hildebrandt, Guido Kobbe, Manuel Aivado, Astrid Rong, Maren Free, Renate Rössig, Roland Fenk, Peter Schneider, Norbert Gattermann, Brigitte Royer-Pokora, Rainer Haas and Ralf Kronenwett

    Version of Record online : 14 JAN 2003, DOI: 10.1034/j.1600-0609.2003.02811.x

  6. Adiponectin enhances Imatinib anti-tumour activity in human chronic myeloid leukaemia cells with serum levels associated with Imatinib efficacy in early chronic phase patients

    Cell Proliferation

    Volume 48, Issue 4, August 2015, Pages: 486–496, Guangshan Tan, Lei Shi, Qiang Li and Mingjun Wang

    Version of Record online : 6 JUL 2015, DOI: 10.1111/cpr.12194

  7. You have free access to this content
    Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia

    British Journal of Haematology

    Volume 137, Issue 4, May 2007, Pages: 297–306, Jörg Westermann, Joachim Kopp, Antje Van Lessen, Ann-Christine Hecker, Gökben Baskaynak, Philipp Le Coutre, Konstanze Döhner, Hartmut Döhner, Bernd Dörken and Antonio Pezzutto

    Version of Record online : 4 APR 2007, DOI: 10.1111/j.1365-2141.2007.06547.x

  8. You have free access to this content
    Response and resistance in 300 patients with BCR-ABL–positive leukemias treated with imatinib in a single center

    Cancer

    Volume 103, Issue 8, 15 April 2005, Pages: 1659–1669, Tanja Lahaye, Birte Riehm, Ute Berger, Peter Paschka, Martin C. Müller, Sebastian Kreil, Kirsten Merx, Uwe Schwindel, Claudia Schoch, Rüdiger Hehlmann and Andreas Hochhaus

    Version of Record online : 3 MAR 2005, DOI: 10.1002/cncr.20922

  9. Chronic Myeloid Leukemia

    Pediatric Hematology, Third Edition

    Irene A.G. Roberts, Inderjeet S. Dokal, Pages: 384–404, 2007

    Published Online : 4 OCT 2007, DOI: 10.1002/9780470987001.ch17

  10. Chronic Myelogenous Leukemia

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt008

  11. You have free access to this content
    Induction of autophagy by Imatinib sequesters Bcr-Abl in autophagosomes and down-regulates Bcr-Abl protein

    American Journal of Hematology

    Volume 88, Issue 6, June 2013, Pages: 455–462, Baukje M. Elzinga, Michelle J. Nyhan, Lisa C. Crowley, Tracey R. O'Donovan, Mary R. Cahill and Sharon L. McKenna

    Version of Record online : 2 APR 2013, DOI: 10.1002/ajh.23428

  12. You have full text access to this Open Access content
    Contribution of BCR–ABL-independent activation of ERK1/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells

    Cancer Science

    Volume 101, Issue 1, January 2010, Pages: 137–142, Takeru Nambu, Norie Araki, Aiko Nakagawa, Akihiko Kuniyasu, Tatsuya Kawaguchi, Akinobu Hamada and Hideyuki Saito

    Version of Record online : 14 SEP 2009, DOI: 10.1111/j.1349-7006.2009.01365.x

  13. You have free access to this content
    Rapid detection of phosphotyrosine proteins by flow cytometric analysis in Bcr-Abl–positive cells

    Cytometry Part A

    Volume 62A, Issue 1, November 2004, Pages: 35–45, Vanessa Desplat, Valérie Lagarde, Francis Belloc, Claudine Chollet, Thibaut Leguay, Jean-Max Pasquet, Vincent Praloran and François-Xavier Mahon

    Version of Record online : 5 OCT 2004, DOI: 10.1002/cyto.a.20030

  14. You have free access to this content
    Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia

    Cancer

    Volume 118, Issue 2, 15 January 2012, Pages: 300–311, Jerald P. Radich

    Version of Record online : 29 JUN 2011, DOI: 10.1002/cncr.26280

  15. You have free access to this content
    Serial monitoring of BCR–ABL by peripheral blood real-time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemia

    British Journal of Haematology

    Volume 118, Issue 3, September 2002, Pages: 771–777, Lihui Wang, Kevin Pearson, Lynne Pillitteri, Julia E. Ferguson and Richard E. Clark

    Version of Record online : 15 AUG 2002, DOI: 10.1046/j.1365-2141.2002.03705.x

  16. You have free access to this content
    Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein

    Cancer

    Volume 100, Issue 7, 1 April 2004, Pages: 1459–1471, Barbara Scappini, Simona Gatto, Francesco Onida, Clara Ricci, Vladimir Divoky, William G. Wierda, Michael Andreeff, Li Dong, Kimberly Hayes, Srdan Verstovsek, Hagop M. Kantarjian and Miloslav Beran

    Version of Record online : 25 FEB 2004, DOI: 10.1002/cncr.20131

  17. You have free access to this content
    Chronic myeloid leukemia with an e13a3 BCR-ABL fusion: Benign course responsive to imatinib with an RT-PCR advisory

    American Journal of Hematology

    Volume 75, Issue 2, February 2004, Pages: 92–95, David S. Snyder, Ross McMahon, Sandra R. Cohen and Marilyn L. Slovak

    Version of Record online : 23 JAN 2004, DOI: 10.1002/ajh.10456

  18. You have free access to this content
    Targeting primary human leukaemia cells with RNA interference: Bcr-Abl targeting inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells

    British Journal of Haematology

    Volume 129, Issue 3, May 2005, Pages: 377–380, Jane ME Withey, Stephen B Marley, Jaspal Kaeda, Amanda J Harvey, Mark R Crompton and Myrtle Y Gordon

    Version of Record online : 14 APR 2005, DOI: 10.1111/j.1365-2141.2005.05468.x

  19. You have free access to this content
    Overproduction of BCR-ABL induces apoptosis in imatinib mesylate-resistant cell lines

    Cancer

    Volume 103, Issue 1, 1 January 2005, Pages: 102–110, Vanessa Desplat, Francis Belloc, Valérie Lagarde, Catherine Boyer, Junia V. Melo, Josy Reiffers, Vincent Praloran and François-Xavier Mahon

    Version of Record online : 22 NOV 2004, DOI: 10.1002/cncr.20758

  20. You have free access to this content
    Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics

    British Journal of Haematology

    Volume 107, Issue 3, December 1999, Pages: 587–599, Branford, Hughes and Rudzki

    Version of Record online : 3 OCT 2008, DOI: 10.1046/j.1365-2141.1999.01749.x